chronic smell and flavor loss epidemiology forecast
Chronic Smell and Flavor Loss Epidemiology
-
Population-based studies indicate that olfactory dysfunction affects a notable proportion of adults, with prevalence increasing significantly with age and reaching higher levels in individuals over 60 years due to age-related sensory decline and cumulative nasal pathology exposure.
-
Post-viral infections are a leading cause of acquired smell loss, and recent evidence from COVID-19 studies shows that olfactory and taste dysfunction are among the most commonly reported symptoms, with a subset of patients experiencing persistent impairment beyond several months.
-
Diagnosis involves ENT evaluation with clinical history, physical examination, and psychophysical testing, supported by imaging (CT/MRI) when needed to identify structural or neurological causes, enabling accurate diagnosis and targeted management.
Chronic Smell and Flavor Loss Epidemiology Forecast in the 7MM
-
2025 Prevalent Cases of Chronic Smell and Flavor Loss: ~69 million
-
2036 Projected Prevalent Cases of Chronic Smell and Flavor Loss: XX
-
Chronic Smell and Flavor Loss Growth Rate (2026–2036): XX% CAGR
DelveInsight's ‘Chronic Smell and Flavor Loss Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the chronic smell and flavor loss, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
|
Study Period
|
2022–2036
|
|
Historical Year
|
2022–2025
|
|
Forecast Period
|
2026–2036
|
|
Base Year
|
2026
|
|
Geographies Covered
|
-
North America: The US;
-
Europe: Germany, France, Italy, Spain, and the UK;
-
Asia-Pacific: Japan
|
|
Chronic Smell And Flavor Loss Epidemiology CAGR
(Forecast period)
|
XX% (2026–2036)
|
|
Chronic Smell And Flavor Loss Epidemiology Segmentation Analysis
|
Patient Burden Assessment
-
Total Prevalent Cases of Chronic Smell and Flavor Loss
-
Total Diagnosed Cases of Chronic Smell and Flavor Loss
-
Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss
-
Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss
-
Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss
-
Total treated Cases of Chronic Smell and Flavor Loss
|
Chronic Smell and Flavor Loss Understanding
Chronic Smell and Flavor Loss Overview
Olfactory and gustatory dysfunction are sensory disorders involving reduced or distorted smell and taste, which gained prominence during the COVID-19 pandemic as common early symptoms. These impairments may result from viral, neurological, autoimmune, or environmental causes, and often occur together due to shared neural pathways.
Further details are provided in the report.
Chronic Smell and Flavor Loss Diagnosis
Diagnosis involves ENT evaluation with clinical history, physical examination, and psychophysical testing, supported by imaging (CT/MRI) when needed to identify structural or neurological causes, enabling accurate diagnosis and targeted management.
Further details are provided in the report.
Chronic Smell and Flavor Loss Epidemiology
Key Findings from Chronic Smell And Flavor Loss Epidemiological Analysis and Forecast
-
According to DelveInsight’s estimates, the United States accounted for the highest number of prevalent cases of Chronic Smell and Flavor Loss in 2025, with approximately 69 million cases among the 7MM.
-
US-based psychophysical testing studies using validated tools (e.g., UPSIT) show that objective smell impairment is significantly higher than self-reported rates, with up to ~50%+ of tested individuals showing measurable dysfunction even without awareness.
-
European COVID-19 cohort studies report that olfactory dysfunction prevalence during infection ranged from ~50–60% in European patients, making it one of the most commonly reported neurological symptoms.
-
In 2025, gender-specific data across the 7MM indicate that females had a higher prevalence of chronic smell and flavor loss compared to males.
Scope of the Report
-
The report covers a segment of a descriptive overview of Chronic Smell And Flavor Loss, explaining their causes, signs and symptoms, and pathogenesis.
-
Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Report Insights
Chronic Smell and Flavor Loss Patient Population Forecast
Report Key Strengths
Key Questions Answered
-
What are the disease risks, burdens, and unmet needs of Chronic Smell And Flavor Loss? What will be the growth opportunities across the 7MM concerning the patient population with Chronic Smell And Flavor Loss?
-
What is the historical and forecasted Chronic Smell And Flavor Loss patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy
-
Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
-
To understand key opinion leaders’ perspectives on the diagnostic challenges to overcome barriers in the future.
-
Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.
Key Insights
Report Introduction
Executive Summary
Epidemiology Forecast Methodology of Chronic Smell and Flavor Loss
Chronic Smell and Flavor Loss Epidemiology Overview at a Glance
- Patient Share (%) Distribution by Country in 2025 in the 7MM
- Patient Share (%) Distribution by Country in 2036 in the 7MM
Disease Background and Overview of Chronic Smell and Flavor Loss
- Introduction
- Causes
- Signs and Symptoms
- Diagnosis
- Differential Diagnosis
- Diagnostic Algorithm
- Diagnostic Guidelines
Epidemiology and Patient Population of Chronic Smell and Flavor Loss
- Key Findings
- Assumption and Rationale
- Total Prevalent Cases of Chronic Smell and Flavor Loss in the 7MM
The United States
- Total Prevalent Cases of Chronic Smell and Flavor Loss in the United States
- Total Diagnosed Cases of Chronic Smell and Flavor Loss in the United States
- Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States
- Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States
- Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States
- Total Treated Cases of Chronic Smell and Flavor Loss in the United States
EU4 and the UK
- Total Prevalent Cases of Chronic Smell and Flavor Loss in the EU4 and the UK
- Total Diagnosed Cases of Chronic Smell and Flavor Loss in the EU4 and the UK
- Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU4 and the UK
- Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU4 and the UK
- Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU4 and the UK
- Total Treated Cases of Chronic Smell and Flavor Loss in the EU4 and the UK
Japan
- Total Prevalent Cases of Chronic Smell and Flavor Loss in Japan
- Total Diagnosed Cases of Chronic Smell and Flavor Loss in Japan
- Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan
- Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan
- Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan
- Total Treated Cases of Chronic Smell and Flavor Loss in Japan
Appendix
- Bibliography
- Report Methodology
DelveInsight Capabilities
Disclaimer
About DelveInsight
List of Tables:
List of Table
Table 1: Summary of Chronic Smell and Flavor Loss, Market, Epidemiology, and Key Events (2021-2034)
Table 2: ODs
Table 3: Causes of Olfactory Disturbance
Table 4: Total Prevalent Population of Chronic Smell and Flavor Loss in the 7MM (2021-2034)
Table 5: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the United States (2021-2034)
Table 6: Total Prevalent Cases of Chronic Smell Loss in the United States (2021-2034)
Table 7: Total Prevalent Cases of Chronic Flavor Loss in the United States (2021-2034)
Table 8: Total Diagnosed Prevalent cases of Chronic Smell and Flavor Loss in the United States (2021-2034)
Table 9: Total Diagnosed Prevalent cases (excluding COVID-19) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Table 10: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Table 11: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Table 12: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Table 13: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the EU5 (2021-2034)
Table 14: Total Prevalent Cases of Chronic Smell Loss in the EU5 (2021-2034)
Table 15: Total Prevalent Cases of Chronic Flavor Loss in the EU5 (2021-2034)
Table 16: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Table 17: Diagnosed Prevalent Cases (excluding COVID-19 patients) in the EU5 (2021-2034)
Table 18: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Table 19: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Table 20: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Table 21: Total Prevalent Cases of Chronic Smell Loss in Japan (2021-2034)
Table 22: Total Prevalent Cases of Chronic Smell Loss in Japan (2021-2034)
Table 23: Total Prevalent Cases of Chronic Flavor Loss in Japan (2021-2034)
Table 24: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in Japan (2021-2034)
Table 25: Total Diagnosed Prevalent Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan (2021-2034)
Table 26: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan (2021-2034)
Table 27: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan (2021-2034)
Table 28: Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan (2021-2034)
List of Figures:
List of Figures
Figure 1: Taste Disorders
Figure 2: Signs and Symptoms of Anosmia/hyposmia
Figure 3: Causes of Taste Disorders
Figure 4: Anatomy of Taste and Olfaction
Figure 5: Possible Pathogenesis of Olfactory Disorders in COVID-19
Figure 6: Treatment Algorithm of Postviral OD
Figure 7: Total Prevalent Population of Chronic Smell and Flavor Loss in the 7MM (2021-2034)
Figure 8: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the United States (2021-2034)
Figure 9: Total Prevalent Cases of Chronic Smell Loss in the United States (2021-2034)
Figure 10: Total Prevalent Cases of Chronic Flavor Loss in the United States (2021-2034)
Figure 11: Total Diagnosed Prevalent cases of Chronic Smell and Flavor Loss in the United States (2021-2034)
Figure 12: Total Diagnosed Prevalent cases (excluding COVID-19) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Figure 13: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Figure 14: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Figure 15: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States (2021-2034)
Figure 16: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the EU5 (2021-2034)
Figure 17: Total Prevalent Cases of Chronic Smell Loss in the EU5 (2021-2034)
Figure 18: Total Prevalent Cases of Chronic Flavor Loss in the EU5 (2021-2034)
Figure 19: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Figure 20: Diagnosed Prevalent Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Figure 21: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Figure 22: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Figure 23: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5 (2021-2034)
Figure 24: Total Prevalent Cases of Chronic Smell and Flavor Loss in Japan (2021-2034)
Figure 25: Total Prevalent Cases of Chronic Smell Loss in Japan (2021-2034)
Figure 26: Total Prevalent Cases of Chronic Flavor Loss in Japan (2021-2034)
Figure 27: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in Japan (2021-2034)
Figure 28: Total Diagnosed Prevalent Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan (2021-2034)
